DNA Vaccine
Transdermal gene delivery eradicates tumors expressing hepatitis C proteins
Published in Hepatitis Weekly, May 5th, 2003
The vaccine, developed by researchers at the Karolinska Institute at Huddinge University Hospital in Stockholm, Sweden, contains the genetic components of HCV nonstructural proteins. The gene gun method of delivery appears particularly suited for its administration, researchers report.
"The HCV protease and helicase encompasses the nonstructural (NS)3 protein and the cofactor NS4A, which targets the NS3/4A complex to intracellular membranes," described L. Frelin and coauthors.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2003-05-05)
More Articles from Hepatitis Weekly
- Radiology
Magnetic resonance spectroscopy could replace the use of HCV-related biopsy - Adoptive Immunotherapy
Roadblocks to tumor vaccines could be overcome with interleukin-2 - Hepatitis C Therapy
The choice to continue therapy for chronic hepatitis C can be made in 12 weeks - Virology
Core-envelope 1-based assays can quickly distinguish hepatitis C virus subtypes - Virology
The Hungarian population is host to several different TT virus genotypes - Chronic Hepatitis C
Soluble ICAM-I correlates with response to retreatment for hepatitis C virus - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
